Skip to main content
. Author manuscript; available in PMC: 2019 Sep 3.
Published in final edited form as: Nat Methods. 2019 Jan 28;16(2):183–190. doi: 10.1038/s41592-018-0305-7

Fig. 2 |. Trogocytosis is titratable and augmented by the presence of CD8.

Fig. 2 |

a-c, Comparison of trogocytosis capability of (a) F5-Jurkat or 1G4-Jurkat cells with HLA-A2 expressing K562 cells (A2-K562) loaded with different doses of MART1 (ELAGIGILTV; top) or NYESO1 (SLLMWITQV; bottom) heteroclitic peptide; (b) F5-Jurkat or 1G4-Jurkat cells with A2-K562 cells loaded with different MART1 (top) or NYESO1 (bottom) peptide variants; and (c) CD8+ or CD8- F5-Jurkat or 1G4-Jurkat cells with MART1-K562 or NYESO1-K562 cells (n = 3). Statistical analysis of quantification was performed using unpaired two-tailed Student’s t-test. Data are presented as mean± s.e.m. and are representative of two independent experiments.